Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Snp Genotyping Market by Product, by Application, by Technology, by End-user, and by Region" report has been added to ResearchAndMarkets.com's offering.

The genotyping assays market was projected to attain US$ 30.5 billion in 2023. It is likely to garner a 22.5% CAGR from 2024 to 2034, and by 2034, the market is expected to attain US$ 285.3 billion.

HOUSTON--(BUSINESS WIRE)--iGenomX International Genomics Corp., provider of the industry’s most scalable sequencing library tools, today launched its Next-Generation Genotyping (NGG) application for ...

The MarketWatch News Department was not involved in the creation of this content. Expansion of personalized medicine approaches that require detailed genetic information to tailor treatments to ...

Genotyping arrays have long supported large-scale SNP analysis, yet limitations remain when seeking flexibility and depth. Traditional workflows often require separate runs for arrays and exome ...

Genotyping assays are essential in a variety of plant and animal applications including Marker Assisted Selection (MAS) and Quantitative Trait Locus (QTL) Mapping. While microarrays and endpoint PCR ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today introduced its 192.24 Dynamic Array™ IFC, designed to genotype 192 samples against 24 SNP assays in a single run, ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NAS: AFFX) announces the introduction of the Axiom ® 384HT genotyping format, a breakthrough cost-effective, high-throughput format for ...

Multiple testing platforms exist for plasma genotyping, each with unique test characteristics and scientific validation. The optimal use and interpretation of plasma genotyping requires understanding ...